Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lee M. Zehngebot"'
Publikováno v:
Journal of Cancer, Vol 3, Iss 1, Pp 152-157 (2012)
Chromophobe kidney cancer accounts for approximately 5% of cases of renal cell carcinoma (RCC). While the genetics of clear cell RCC has been a major focus of research, little is known about the biology of chromophobe tumors. There is ample preclinic
Externí odkaz:
https://doaj.org/article/ef5d411758f94729a9ed1eda986c4064
Autor:
Srinivas Vourganti, Julia Friend, Lee M. Zehngebot, Ramaprasad Srinivasan, W. Marston Linehan, Brian Shuch
Publikováno v:
Journal of Cancer
Chromophobe kidney cancer accounts for approximately 5% of cases of renal cell carcinoma (RCC). While the genetics of clear cell RCC has been a major focus of research, little is known about the biology of chromophobe tumors. There is ample preclinic
Autor:
James M. Provenzale, Lee M. Zehngebot, Gamal Akabani, Cynthia D. Guy, Michael R. Zalutsky, Allan H. Friedman, Carol J. Wikstrand, Henry S. Friedman, Ilkcan Cokgor, Darell D. Bigner
Publikováno v:
Cancer. 91:1809-1813
Even with novel chemotherapeutic agents and external beam radiation therapy, the prognosis of neoplastic meningitis secondary to malignant melanoma is still dismal. The authors report a case study of a 46-year-old white female who presented with prog
Autor:
Melhem Solh, Raul Castillo, Carlos Alemany, Ahmed Zakari, Sarah George, R. Reynolds, Linda Lukman, Lee M. Zehngebot, Yasser Khaled
Publikováno v:
Blood. 120:4521-4521
Abstract 4521 Continuity of care (COC) is acknowledged as a core quality measure in HIV, heart failure and family medicine. Allogeneic hematopoietic stem cell transplantation (Allo-HCT) is complex therapeutic option where is the selection of patient,
Autor:
Robert Z. Orlowski, Lee M. Zehngebot, Bercedis L. Peterson, Ben L. Sanford, Asher A. Chanan-Khan, Richard A. Larson, Peter R. Watson, Michael A. Caligiuri
Publikováno v:
Blood. 108:797-797
Introduction: The proteasome inhibitor bortezomib in combination with pegylated, liposomal doxorubicin (PLD) has significant activity against relapsed/refractory multiple myeloma (MM). It was therefore of interest to evaluate this combination in prev
Publikováno v:
American Journal of Otolaryngology. 1:306-323
This review highlights the most important recent advances in the chemotherapeutic management of patients with squamous cell carcinoma of the head and neck. Previous chemotherapy trials must be interpreted with caution in the absence of information co
Autor:
Meenhard Herlyn, Kenneth Frank Mitchell, Lee M. Zehngebot, Douglas B. Cines, DuPont Guerry, Michael A. Alexander
Publikováno v:
Cancer Immunology, Immunotherapy. 16:30-34
Melanoma cells have been shown to express melanoma-associated antigens and, in many cases, the histocompatibility antigen, HLA-DR. We questioned whether the expression of these antigens was quantitatively altered during the serial passage of melanoma
Publikováno v:
Cancer. 53:A17-A17